Recombinant Protein ISO 9001|ABMIUM Verified™
ABM100808

Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5)

ISO 9001|ABMIUM Verified™|Protein

Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5) from ELK Biotechnology Read more ›

Related formats
No image available

Product Description

Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5) is an ELK Biotechnology recombinant protein for research use.

Description

The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Background

The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Handling information

Delivery condition The product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below.

Key Facts

Product type Recombinant Protein Target: Anti-2019-nCoV S-mIgG1 Neutralizing Antibody
Target Anti-2019-nCoV S-mIgG1 Neutralizing Antibody
Form / buffer Lyophilized protein
Research area Infectious Diseases, Molecular Biology
Why researchers trust ABMIUM
2,000+ Researchers trust us
50,000+ Citations
ISO 9001 Certified Collaborators

1 specification
ABMIUM Validated™ ABMIUM Verified™ Expected Performance Not suitable
SpecificationPURITYENDOTOXINBIOACTIVITY
Product QC

Specifications

Target
Anti-2019-nCoV S-mIgG1 Neutralizing Antibody
Form / buffer
Lyophilized protein

Storage & Stability

Long-term storage
Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Storage conditions
Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.

Compliance & Certifications

ISO 9001
ISO 9001:2015 Certified

Manufactured under ISO 9001:2015 quality management standards.

RUO
For Research Use Only

Not intended for diagnostic or therapeutic use.

Customer Reviews

Recently Viewed